Vibramycin and Ceftin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vibramycin (doxycycline) and Ceftin (cefuroxime axetil). Common drug interactions include cardioactive drug level decreased among females and chlamydial infection among males.

The phase IV clinical study analyzes what interactions people have when they take Vibramycin and Ceftin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Vibramycin?

Vibramycin has active ingredients of doxycycline. It is often used in acne. eHealthMe is studying from 1,692 Vibramycin users. Check the latest studies of Vibramycin.

What is Ceftin?

Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. eHealthMe is studying from 4,333 Ceftin users. Check the latest studies of Ceftin.



On Aug, 06, 2026

13 people who take Vibramycin and Ceftin together, and have interactions are studied.

Vibramycin and Ceftin drug interactions.

What are the common drug interactions of Vibramycin and Ceftin, by gender? *:

female:

  1. Cardioactive drug level decreased
  2. Cardiomegaly (increased size of heart than normal)
  3. Chest pain
  4. Chills (felling of cold)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Concussion (short loss of normal brain function in response to a head injury)
  7. Constipation
  8. Decreased appetite
  9. Deformity (disfigurement)
  10. Depressed level of consciousness

male:

  1. Chlamydial infection (a common sexually transmitted infection (sti) in humans caused by the bacterium chlamydia trachomatis)
  2. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Haemoglobin decreased
  6. Hydronephrosis (water inside the kidney)
  7. Hypersomnia (excessive daytime sleepiness (eds))
  8. Hypertension (high blood pressure)
  9. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  10. Kidney infection

What are the common drug interactions of Vibramycin and Ceftin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Pulmonary infarction (death of a small area of lung)

30-39:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Drug dependence
  3. Exacerbation of anxiety (increase in the severity of anxiety)
  4. Anger
  5. Drug effect decreased
  6. Sedation
  7. Aggression
  8. Concussion (short loss of normal brain function in response to a head injury)
  9. Depression
  10. Family stress

40-49:

  1. Rash
  2. Chlamydial infection (a common sexually transmitted infection (sti) in humans caused by the bacterium chlamydia trachomatis)
  3. Gonorrhoea (a common human sexually transmitted infection caused by the bacterium neisseria gonorrhoea)
  4. Nausea (feeling of having an urge to vomit)
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

50-59:

n/a

60+:

  1. Hypertension (high blood pressure)
  2. Back pain
  3. Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
  4. Anaemia (lack of blood)
  5. Anxiety
  6. Aortic thrombosis (formation of a blood clot inside aorta)
  7. Aortic valve incompetence
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Asthenia (weakness)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

  1. Pain: 3 people, 23.08%
  2. Back Pain: 2 people, 15.38%
  3. Pulmonary Congestion (congestion in the lungs): 2 people, 15.38%
  4. Nausea (feeling of having an urge to vomit): 2 people, 15.38%
  5. Cardiac Disorder: 2 people, 15.38%
  6. Tumor: 1 person, 7.69%
  7. High Blood Pressure: 1 person, 7.69%
  8. Blood Pressure Abnormal: 1 person, 7.69%
  9. Bone Disorder: 1 person, 7.69%
  10. Cardiac Failure Congestive: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vibramycin and Ceftin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vibramycin and Ceftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vibramycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ceftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vibramycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on doxycycline and cefuroxime axetil (the active ingredients of Vibramycin and Ceftin, respectively), and Vibramycin and Ceftin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: